Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled …
…, AV Pastor, SN Sena, JJ Zarba, O Burghuber, S Hartl… - The Lancet, 2019 - thelancet.com
Background Most patients with small-cell lung cancer (SCLC) have extensive-stage disease
at presentation, and prognosis remains poor. Recently, immunotherapy has demonstrated …
at presentation, and prognosis remains poor. Recently, immunotherapy has demonstrated …
Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer …
…, S Valev, MAI Molla, G Ursol, A Chiang, S Hartl… - The Lancet …, 2021 - thelancet.com
Background First-line durvalumab plus etoposide with either cisplatin or carboplatin (platinum–etoposide)
showed a significant improvement in overall survival versus platinum–…
showed a significant improvement in overall survival versus platinum–…
Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis
VS Benson, S Hartl, N Barnes, N Galwey… - European …, 2022 - Eur Respiratory Soc
Background The clinical context for using blood eosinophil (EOS) counts as treatment–response
biomarkers in asthma and COPD requires better understanding of EOS distributions …
biomarkers in asthma and COPD requires better understanding of EOS distributions …
Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled …
…, D Köhler, A Drabik, J Geiseler, S Hartl… - The Lancet …, 2014 - thelancet.com
Background Evidence is weak for the ability of long-term non-invasive positive pressure
ventilation (NPPV) to improve survival in patients with stable hypercapnic chronic obstructive …
ventilation (NPPV) to improve survival in patients with stable hypercapnic chronic obstructive …
Incidence and outcome of weaning from mechanical ventilation according to new categories
…, A Valentin, S Hartl - European …, 2010 - Eur Respiratory Soc
… Questions about the weaning procedures were encouraged and were answered by the
authors (S. Anders, S. Hartl or W. Heindl) at any time before and during the study. While the …
authors (S. Anders, S. Hartl or W. Heindl) at any time before and during the study. While the …
Differences in content and organisational aspects of pulmonary rehabilitation programmes
… Programmes were more likely to be reimbursed in Europe by the government, while in North
America the programmes were more likely to be reimbursed by the patient’s insurance or …
America the programmes were more likely to be reimbursed by the patient’s insurance or …
[HTML][HTML] Nordic walking improves daily physical activities in COPD: a randomised controlled trial
…, MA Spruit, EFM Wouters, OC Burghuber, S Hartl - Respiratory …, 2010 - Springer
… than one plane of movement and therefore time spent walking, standing, sitting or lying, as
well as the movement intensity, which is given in meters divided by seconds squared (m/s 2 ), …
well as the movement intensity, which is given in meters divided by seconds squared (m/s 2 ), …
Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit
S Hartl, JL Lopez-Campos… - European …, 2016 - Eur Respiratory Soc
Studies report high in-hospital and post-discharge mortality of chronic obstructive pulmonary
disease (COPD) exacerbations varying depending upon patient characteristics, hospital …
disease (COPD) exacerbations varying depending upon patient characteristics, hospital …
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3 …
Background Doravirine is a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) with
a pharmacokinetic profile supporting once-daily dosing, and potent in-vitro activity against …
a pharmacokinetic profile supporting once-daily dosing, and potent in-vitro activity against …
End-of-life decision-making in respiratory intermediate care units: a European survey
S Nava, C Sturani, S Hartl, G Magni… - European …, 2007 - Eur Respiratory Soc
A survey was performed on behalf of the European Respiratory Society to assess end-of-life
practices in patients admitted to European respiratory intermediate care units and high …
practices in patients admitted to European respiratory intermediate care units and high …